It was recently demonstrated that the presence of serological IgA is superior to IgM as an early serological marker of recent SARS-CoV-2 infection, demonstrating the importance of IgA in the disease progression [30,31] and in the prediction of the clinical course of COVID-19 [32]. This evidence concerns the gene CD79A and COVID-19.